"Dec. 18, 2012 -- Taking aspirin regularly appears to slightly raise the risk of the eye condition known as age-related macular degeneration or AMD, new research suggests.
The increased risk only occurred with people who had taken aspi"...
Clinical Studies Experience
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
In clinical studies with ZYMAXID™ (gatifloxacin ophthalmic solution) , the most frequently reported adverse reactions occurring in ≥ 1 % of patients in the gatifloxacin study population (N=717) were: worsening of the conjunctivitis, eye irritation, dysgeusia, and eye pain.
Additional adverse events reported with other formulations of gatifloxacin ophthalmic solution include chemosis, conjunctival hemorrhage, dry eye, eye discharge, eyelid edema, headache, increased lacrimation, keratitis, papillary conjunctivitis, and reduced visual acuity.
Read the Zymaxid (gatifloxacin ophthalmic solution) Side Effects Center for a complete guide to possible side effects
Specific drug interaction studies have not been conducted with ZYMAXID™ (gatifloxacin ophthalmic solution) ophthalmic solution.
Last reviewed on RxList: 6/23/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Zymaxid Information
Report Problems to the Food and Drug Administration
Get breaking medical news.